The North America software as a medical device market is expected to reach US$ 39,854.20 million by 2027 from US$ 8,353.94 million in 2019

The market is anticipated to grow at a CAGR of 22. 2% from 2020 to 2027. The growth of the market is attributed to the increasing adoption of IoT in healthcare and advantages of software as medical device (SaMD).


New York, May 19, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "North America Software as a Medical Device Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Device Type, Application, Deployment Type, and Country" - https://www.reportlinker.com/p05894578/?utm_source=GNW
On the other hand, the threat of data breach hinders the growth of market.
The growth of the market is highly dependent on technological advancements.The North American technology players have been increasingly partnering with pharmaceuticals companies.

For instance, BrightInsight entered into a Global Digital Health Partnership with AstraZeneca to build and manage its digital health solutions within a regulatory-compliant environment. Similarly, CompliancePath and Ideagen have entered into a Product Validation partnership to extend their ongoing validation accelerator program to include all life science-related software products.
The North America Software as medical device market, based on the device type, is segmented into smartphones/tablets, wearable devices, and PC/laptops.In 2019, smartphones/tablets segment held the largest share of the market.

However, wearable devices segment is expected register the highest CAGR during the forecast period.The North America Software as medical device market, based on application, is segmented into screening and diagnosis, monitoring and alerting, and disease management.

In 2019, screening and diagnosis segment held the largest share of the market.However, the monitoring and alerting segment is expected to grow at the fastest rate during the forecast period.

The North America Software as medical device market, based on the deployment type, is segmented into cloud and on-premises. In 2019, the cloud segment held the largest share of the market, and it is also expected to register the highest CAGR during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the Software as Medical device include the World Health Organization, Food and Drug Administration, Centers for Disease Control and Prevention (CDC), and Pan American Health Organization.
Read the full report: https://www.reportlinker.com/p05894578/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________


            

Contact Data